News
12h
TipRanks on MSNAbbVie’s ABBV-319 Study: A Potential Game-Changer in B-cell Malignancies
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a clinical study titled ‘A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results